Interleukin-17A Antagonist [EPC]

Interleukin-17A Antagonist [EPC] was reported 37285 times

Drugs of the Interleukin-17A Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MENINGORADICULITIS 10 0.0926
1 DOUBLE STRANDED DNA ANTIBODY 9 0.0789
2 CHRONIC DISEASE 20 0.0784
3 INJECTION SITE PLAQUE 15 0.0714
4 REMOVAL OF INTERNAL FIXATION 10 0.0565
5 ALOPECIA SCARRING 10 0.0546
6 PSORIASIS AREA SEVERITY INDEX INCREASED 9 0.0545
7 CUTANEOUS LYMPHOMA 11 0.0539
8 CARBON DIOXIDE ABNORMAL 15 0.0479
9 GRANULOMA SKIN 35 0.0426
10 SAPHO SYNDROME 10 0.0405
11 SKIN CANDIDA 19 0.0364
12 DACTYLITIS 35 0.0356
13 SELF-CONSCIOUSNESS 9 0.0354
14 ENTHESOPATHY 55 0.0351
15 PARADOXICAL PSORIASIS 14 0.0299
16 WRONG SCHEDULE 28 0.0294
17 PALMOPLANTAR PUSTULOSIS 15 0.0284
18 INJECTION SITE URTICARIA 676 0.0275
19 BLOOD PARATHYROID HORMONE DECREASED 39 0.0263
20 INJECTION SITE REACTION 1798 0.0261
21 NAIL PSORIASIS 16 0.0259
22 PANCREATIC STEATOSIS 7 0.0257
23 NAIL PITTING 10 0.0253
24 PSORIASIS 3296 0.0252
25 INJECTION SITE HYPERSENSITIVITY 77 0.0246
26 INJECTION SITE WARMTH 501 0.0243
27 GENERALISED PUSTULAR PSORIASIS 7 0.0241
28 MANUFACTURING PRODUCT SHIPPING ISSUE 13 0.0239
29 INJECTION SITE CELLULITIS 44 0.0237
30 CIRRHOSIS ALCOHOLIC 10 0.0218
31 DUPLICATE THERAPY ERROR 7 0.0218
32 TINEA INFECTION 24 0.0217
33 INJECTION SITE SWELLING 1659 0.0216
34 ERYTHRODERMIC PSORIASIS 17 0.0206
35 ANTIBIOTIC THERAPY 20 0.0205
36 PSORIATIC ARTHROPATHY 821 0.0202
37 TINEA CRURIS 10 0.0201
38 RHEUMATOID NODULE 53 0.0192
39 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 45 0.0189
40 REBOUND PSORIASIS 11 0.0189
41 INJECTION SITE OEDEMA 32 0.0186
42 GUTTATE PSORIASIS 15 0.0183
43 TINEA PEDIS 29 0.0182
44 INJECTION SITE RASH 549 0.0179
45 INJECTION SITE ERYTHEMA 2214 0.0178
46 ASYMPTOMATIC COVID-19 7 0.0178
47 LOCAL REACTION 13 0.0175
48 INJECTION SITE INFLAMMATION 87 0.0174
49 PUSTULAR PSORIASIS 59 0.0172
50 INJECTION SITE MASS 622 0.0168
51 DYSHIDROTIC ECZEMA 12 0.0167
52 PANNICULITIS 39 0.0161
53 PHARYNGEAL ABSCESS 8 0.0159
54 CUTANEOUS T-CELL LYMPHOMA 20 0.0159
55 ONYCHOLYSIS 24 0.0153
56 SKIN NEOPLASM EXCISION 12 0.0153
57 DERMATITIS PSORIASIFORM 31 0.0152
58 MECHANICAL URTICARIA 7 0.0149
59 INFLAMMATORY BOWEL DISEASE 145 0.0148
60 SACRAL PAIN 9 0.0148
61 INJECTION SITE INDURATION 189 0.0146
62 ACCIDENTAL UNDERDOSE 203 0.0141
63 INJECTION RELATED REACTION 22 0.0133
64 INFLAMMATORY PAIN 9 0.0133
65 CARBON DIOXIDE DECREASED 15 0.0130
66 INJECTION SITE PAIN 3931 0.0128
67 ORAL CANDIDIASIS 168 0.0127
68 IMPETIGO 19 0.0127
69 DEMYELINATING POLYNEUROPATHY 13 0.0126
70 TUBERCULIN TEST POSITIVE 32 0.0126
71 INJECTION SITE DISCOMFORT 132 0.0125
72 DRUG TOLERANCE DECREASED 35 0.0125
73 INJECTION SITE PRURITUS 806 0.0120
74 THERAPY INTERRUPTED 845 0.0118
75 INJECTION SITE INJURY 65 0.0117
76 ANGULAR CHEILITIS 8 0.0116
77 RED BLOOD CELLS URINE POSITIVE 11 0.0114
78 PHARYNGITIS STREPTOCOCCAL 123 0.0114
79 FUNGAL OESOPHAGITIS 8 0.0113
80 TONSIL CANCER 9 0.0112
81 TONSILLAR DISORDER 12 0.0107
82 WEST NILE VIRAL INFECTION 8 0.0107
83 STAPHYLOCOCCAL SKIN INFECTION 13 0.0106
84 MALIGNANT MELANOMA IN SITU 13 0.0105
85 AXIAL SPONDYLOARTHRITIS 9 0.0102
86 DIFFUSE ALOPECIA 19 0.0102
87 ACTINIC KERATOSIS 26 0.0100
88 TREATMENT DELAYED 17 0.0098
89 ANKYLOSING SPONDYLITIS 128 0.0097
90 PUSTULE 23 0.0097
91 INFECTION REACTIVATION 11 0.0096
92 LATENT TUBERCULOSIS 20 0.0095
93 B-CELL TYPE ACUTE LEUKAEMIA 7 0.0095
94 CANDIDA INFECTION 161 0.0095
95 ORAL FUNGAL INFECTION 26 0.0095
96 EAR INFECTION 251 0.0094
97 VITILIGO 22 0.0094
98 CONTRAINDICATION TO MEDICAL TREATMENT 14 0.0092
99 STREPTOCOCCAL INFECTION 51 0.0092
100 ONYCHALGIA 9 0.0090
101 DERMATITIS EXFOLIATIVE GENERALISED 31 0.0089
102 SKIN STRIAE 13 0.0087
103 INJECTION SITE PARAESTHESIA 13 0.0085
104 LIPIDS INCREASED 17 0.0084
105 ANGIOPLASTY 12 0.0080
106 SACROILIITIS 15 0.0079
107 INCORRECT PRODUCT FORMULATION ADMINISTERED 7 0.0079
108 INJECTION SITE HAEMORRHAGE 629 0.0079
109 T-CELL LYMPHOMA 9 0.0079
110 THERAPY CESSATION 402 0.0078
111 FUNGAL SKIN INFECTION 31 0.0077
112 MUCOSAL DRYNESS 15 0.0074
113 ORCHITIS 8 0.0074
114 ALOPECIA AREATA 13 0.0074
115 TOOTH INFECTION 97 0.0074
116 SKIN NECROSIS 38 0.0073
117 AGORAPHOBIA 10 0.0073
118 CELLULITIS 368 0.0073
119 LYMPHADENECTOMY 7 0.0072
120 OESOPHAGEAL CANDIDIASIS 28 0.0070
121 ACQUIRED HAEMOPHILIA 7 0.0070
122 INJECTION SITE VESICLES 42 0.0069
123 BREATH SOUNDS ABNORMAL 34 0.0069
124 INTERCEPTED PRODUCT PRESCRIBING ERROR 9 0.0068
125 THERAPEUTIC PRODUCT EFFECT DECREASED 303 0.0068
126 INJECTION SITE IRRITATION 86 0.0068
127 FUNGAL INFECTION 222 0.0067
128 SEBORRHOEIC DERMATITIS 11 0.0067
129 CEREBRAL VENOUS THROMBOSIS 12 0.0066
130 OTITIS EXTERNA 8 0.0065
131 HERNIA REPAIR 17 0.0065
132 LICHEN PLANUS 15 0.0065
133 AMYLOIDOSIS 11 0.0064
134 IMMUNE SYSTEM DISORDER 84 0.0064
135 ERYSIPELAS 32 0.0064
136 OTORRHOEA 11 0.0063
137 INDURATION 11 0.0062
138 SKIN PLAQUE 52 0.0062
139 INJECTION SITE BRUISING 487 0.0061
140 SERUM SICKNESS 17 0.0061
141 VEIN RUPTURE 10 0.0060
142 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 10 0.0059
143 VULVOVAGINAL CANDIDIASIS 8 0.0059
144 SARS-COV-2 TEST POSITIVE 78 0.0059
145 RHEUMATOID FACTOR POSITIVE 34 0.0059
146 WRONG DOSE 14 0.0058
147 BRONCHIAL DISORDER 9 0.0058
148 EAR SWELLING 12 0.0057
149 INJECTION SITE SCAR 16 0.0056
150 INJECTION SITE HYPOAESTHESIA 8 0.0056
151 SKIN INFECTION 62 0.0055
152 CUTANEOUS VASCULITIS 20 0.0055
153 UPPER RESPIRATORY TRACT INFECTION 253 0.0055
154 FURUNCLE 43 0.0054
155 TONSILLECTOMY 9 0.0054
156 TONSILLITIS 28 0.0054
157 VULVOVAGINAL MYCOTIC INFECTION 21 0.0053
158 VARICELLA ZOSTER VIRUS INFECTION 11 0.0053
159 THERAPY NON-RESPONDER 238 0.0053
160 COVID-19 923 0.0053
161 INCORRECT DOSE ADMINISTERED 1199 0.0052
162 MILIARIA 9 0.0052
163 BASAL CELL CARCINOMA 81 0.0052
164 BODY MASS INDEX INCREASED 7 0.0052
165 TENOSYNOVITIS 14 0.0051
166 APHTHOUS ULCER 39 0.0050
167 LOSS OF THERAPEUTIC RESPONSE 16 0.0050
168 B-CELL LYMPHOMA 17 0.0050
169 SINUSITIS 504 0.0049
170 IRRITABLE BOWEL SYNDROME 105 0.0049
171 NAIL INFECTION 7 0.0049
172 RED BLOOD CELL SEDIMENTATION RATE INCREASED 54 0.0049
173 COLITIS MICROSCOPIC 23 0.0049
174 INTERCEPTED PRODUCT DISPENSING ERROR 8 0.0048
175 NECROTISING FASCIITIS 17 0.0048
176 INJECTION SITE DISCOLOURATION 60 0.0048
177 NECK SURGERY 11 0.0047
178 SPINAL OPERATION 57 0.0046
179 INJECTION SITE INFECTION 15 0.0046
180 ARTHRITIS 358 0.0045
181 GUILLAIN-BARRE SYNDROME 22 0.0045
182 MYELITIS 7 0.0045
183 EYE INFECTION 51 0.0045
184 APPENDICECTOMY 16 0.0045
185 INTENTIONAL DOSE OMISSION 127 0.0045
186 PYODERMA GANGRENOSUM 16 0.0044
187 SHOULDER OPERATION 19 0.0044
188 ILLNESS 454 0.0044
189 MALIGNANT MELANOMA 59 0.0044
190 EJECTION FRACTION DECREASED 68 0.0044
191 PARADOXICAL DRUG REACTION 16 0.0043
192 DEAFNESS 113 0.0043
193 PHARYNGEAL SWELLING 42 0.0043
194 EMERGENCY CARE 13 0.0043
195 DECREASED IMMUNE RESPONSIVENESS 42 0.0043
196 GALLBLADDER OPERATION 17 0.0042
197 PHARYNGITIS 52 0.0042
198 HORDEOLUM 18 0.0042
199 TREATMENT FAILURE 339 0.0041
200 COLONOSCOPY 9 0.0041
201 PAPILLARY THYROID CANCER 7 0.0040
202 INFECTIOUS MONONUCLEOSIS 9 0.0040
203 SARCOIDOSIS 19 0.0040
204 INJURY ASSOCIATED WITH DEVICE 81 0.0040
205 SQUAMOUS CELL CARCINOMA OF SKIN 24 0.0040
206 LOCALISED INFECTION 96 0.0040
207 OTITIS MEDIA 13 0.0039
208 FEAR OF INJECTION 28 0.0039
209 ARTHROPOD BITE 29 0.0039
210 SYNOVITIS 70 0.0039
211 OPHTHALMIC HERPES ZOSTER 7 0.0039
212 IMMUNOSUPPRESSION 34 0.0039
213 DEFAECATION URGENCY 27 0.0038
214 SPINA BIFIDA 8 0.0038
215 INGROWING NAIL 9 0.0038
216 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 680 0.0038
217 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 263 0.0037
218 SKIN DISORDER 123 0.0037
219 INFLAMMATION 190 0.0037
220 INFLUENZA 408 0.0037
221 LIMB MASS 8 0.0036
222 INFECTION 525 0.0036
223 MIDDLE EAR EFFUSION 8 0.0036
224 FOLLICULITIS 38 0.0036
225 MULTIPLE ALLERGIES 28 0.0036
226 TONGUE ULCERATION 12 0.0035
227 RESPIRATORY TRACT INFECTION 92 0.0035
228 NASOPHARYNGITIS 647 0.0035
229 CONJUNCTIVITIS 65 0.0035
230 STAPHYLOCOCCAL INFECTION 115 0.0035
231 APPETITE DISORDER 23 0.0035
232 UVEITIS 47 0.0035
233 PRODUCT DOSE OMISSION 226 0.0035
234 DRUG ERUPTION 61 0.0034
235 UNDERDOSE 251 0.0034
236 HYPERSENSITIVITY VASCULITIS 9 0.0034
237 ABDOMINAL TENDERNESS 17 0.0034
238 HERPES ZOSTER 196 0.0034
239 SKIN ULCER 88 0.0034
240 ESCHERICHIA BACTERAEMIA 8 0.0034
241 PRURITUS GENITAL 8 0.0034
242 BONE EROSION 12 0.0034
243 SPINAL STENOSIS 14 0.0034
244 HEPATIC STEATOSIS 63 0.0034
245 ANIMAL BITE 9 0.0034
246 ONYCHOMADESIS 14 0.0033
247 LUNG ADENOCARCINOMA 10 0.0033
248 HYPERCALCAEMIA 41 0.0033
249 DEVICE DEFECTIVE 57 0.0033
250 PRODUCT DOSE OMISSION ISSUE 962 0.0033
251 ULCER 52 0.0033
252 BOWEL MOVEMENT IRREGULARITY 25 0.0033
253 KIDNEY INFECTION 64 0.0033
254 CARDIAC OPERATION 28 0.0033
255 JAW FRACTURE 7 0.0032
256 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 21 0.0032
257 PULMONARY FIBROSIS 62 0.0032
258 PRODUCT DISPENSING ERROR 70 0.0032
259 SKIN LESION 88 0.0032
260 C-REACTIVE PROTEIN INCREASED 116 0.0032
261 ENDOMETRIAL CANCER 7 0.0032
262 URTICARIA 532 0.0032
263 ACCIDENT AT WORK 7 0.0032
264 COLITIS 120 0.0032
265 PRESCRIBED OVERDOSE 61 0.0031
266 BRONCHITIS 233 0.0031
267 DIVERTICULITIS 87 0.0031
268 INGUINAL HERNIA 19 0.0031
269 THERAPEUTIC PRODUCT INEFFECTIVE 12 0.0031
270 MENISCUS INJURY 19 0.0031
271 EXTRA DOSE ADMINISTERED 125 0.0031
272 POST PROCEDURAL INFECTION 25 0.0031
273 FACIAL PARALYSIS 26 0.0030
274 SWELLING OF EYELID 19 0.0030
275 SPONDYLITIS 11 0.0030
276 MASS 42 0.0030
277 LYME DISEASE 10 0.0030
278 BREAST SWELLING 8 0.0030
279 INJECTION SITE DISCHARGE 16 0.0030
280 SQUAMOUS CELL CARCINOMA 28 0.0030
281 CRANIOCEREBRAL INJURY 9 0.0030
282 PROSTATITIS 9 0.0030
283 GRIP STRENGTH DECREASED 26 0.0030
284 VIRAL INFECTION 97 0.0029
285 THERAPEUTIC RESPONSE SHORTENED 96 0.0029
286 DIARRHOEA HAEMORRHAGIC 27 0.0029
287 COLITIS ULCERATIVE 129 0.0029
288 RASH MORBILLIFORM 8 0.0029
289 SKIN MASS 19 0.0028
290 GASTROENTERITIS VIRAL 51 0.0028
291 ARTHRITIS INFECTIVE 13 0.0028
292 OVERWEIGHT 15 0.0028
293 ROSACEA 13 0.0028
294 ECZEMA 146 0.0028
295 LIP PAIN 8 0.0028
296 BACTERIAL INFECTION 52 0.0028
297 TOOTH ABSCESS 28 0.0027
298 INSURANCE ISSUE 42 0.0027
299 THERAPY CHANGE 27 0.0027
300 CORONAVIRUS INFECTION 18 0.0027
301 HYPERKERATOSIS 15 0.0027
302 SUBCUTANEOUS ABSCESS 13 0.0027
303 KNEE ARTHROPLASTY 57 0.0027
304 OROPHARYNGEAL PAIN 248 0.0027
305 BLOOD ALBUMIN DECREASED 21 0.0026
306 BURSITIS 32 0.0026
307 SCAB 30 0.0026
308 CHOLECYSTECTOMY 30 0.0026
309 INJECTION SITE PAPULE 12 0.0026
310 GASTRIC INFECTION 10 0.0026
311 CYSTITIS 83 0.0026
312 SYNOVIAL CYST 12 0.0026
313 GINGIVITIS 14 0.0026
314 EAR CONGESTION 7 0.0026
315 PANIC DISORDER 10 0.0026
316 INVASIVE DUCTAL BREAST CARCINOMA 7 0.0026
317 SPLENOMEGALY 30 0.0026
318 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 121 0.0025
319 HYPERSENSITIVITY 467 0.0025
320 DRUG INTOLERANCE 242 0.0025
321 C-REACTIVE PROTEIN ABNORMAL 16 0.0025
322 DRUG INEFFECTIVE 3287 0.0025
323 PRODUCT DISTRIBUTION ISSUE 23 0.0025
324 URINARY TRACT INFECTION 421 0.0025
325 MUSCULOSKELETAL STIFFNESS 216 0.0025
326 THERAPEUTIC RESPONSE DECREASED 149 0.0025
327 GASTROINTESTINAL INFECTION 22 0.0025
328 KNEE OPERATION 24 0.0024
329 ARTHRITIS BACTERIAL 10 0.0024
330 NEPHROLITHIASIS 111 0.0024
331 CYST 30 0.0024
332 VASCULITIS 28 0.0024
333 CHEILITIS 13 0.0024
334 LYMPHADENOPATHY 85 0.0024
335 HAND FRACTURE 17 0.0024
336 SCRATCH 25 0.0024
337 RHINITIS 19 0.0024
338 APPENDICITIS 22 0.0024
339 RASH PUSTULAR 17 0.0023
340 LARGE INTESTINE POLYP 16 0.0023
341 ARTHROPATHY 128 0.0023
342 ORAL INFECTION 9 0.0023
343 TENDERNESS 24 0.0023
344 DUODENITIS 7 0.0023
345 EAR PRURITUS 8 0.0023
346 CONTRAINDICATED PRODUCT ADMINISTERED 69 0.0023
347 JOINT SWELLING 273 0.0023
348 TENDONITIS 35 0.0023
349 CHOLANGITIS 14 0.0023
350 HERPES VIRUS INFECTION 13 0.0023
351 SURGERY 132 0.0022
352 INCORRECT DOSAGE ADMINISTERED 11 0.0022
353 BLEPHARITIS 9 0.0022
354 INTRACRANIAL ANEURYSM 9 0.0022
355 ANAL ABSCESS 12 0.0022
356 NODULE 29 0.0022
357 MATERNAL EXPOSURE DURING BREAST FEEDING 9 0.0022
358 SKIN REACTION 31 0.0022
359 PULMONARY CONGESTION 29 0.0022
360 NONSPECIFIC REACTION 12 0.0022
361 EAR DISORDER 10 0.0022
362 ARTHRALGIA 906 0.0022
363 SYMPTOM RECURRENCE 13 0.0022
364 VULVOVAGINAL PRURITUS 11 0.0022
365 NAIL DISORDER 19 0.0022
366 TOE AMPUTATION 11 0.0022
367 LARGE INTESTINE PERFORATION 15 0.0022
368 POLYP 14 0.0021
369 MATERNAL EXPOSURE TIMING UNSPECIFIED 8 0.0021
370 SKIN TIGHTNESS 10 0.0021
371 JOINT INJURY 45 0.0021
372 VIRAL UPPER RESPIRATORY TRACT INFECTION 10 0.0021
373 PRURITUS 808 0.0021
374 ORAL HERPES 41 0.0021
375 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 36 0.0021
376 OSTEOMYELITIS 38 0.0021
377 HIDRADENITIS 19 0.0021
378 MUSCLE STRAIN 18 0.0021
379 GASTROINTESTINAL DISORDER 186 0.0021
380 SWELLING 194 0.0021
381 HEPATITIS 53 0.0021
382 LYMPHOMA 32 0.0021
383 ABSCESS 33 0.0021
384 GOUT 37 0.0021
385 PRESCRIBED UNDERDOSE 41 0.0021
386 ORAL DISORDER 15 0.0020
387 RENAL CELL CARCINOMA 10 0.0020
388 INFLUENZA LIKE ILLNESS 168 0.0020
389 NAIL DISCOLOURATION 8 0.0020
390 PRURITUS GENERALISED 44 0.0020
391 ANGIOEDEMA 90 0.0020
392 RASH PRURITIC 110 0.0020
393 INCORRECT DOSE ADMINISTERED BY DEVICE 53 0.0020
394 SINUS HEADACHE 12 0.0020
395 MUCOUS STOOLS 10 0.0020
396 PERIPHERAL SWELLING 311 0.0020
397 HEPATITIS B 12 0.0020
398 PEMPHIGOID 15 0.0020
399 PAPULE 14 0.0020
400 CORONARY ARTERIAL STENT INSERTION 10 0.0020
401 GLOSSITIS 7 0.0020
402 SPINAL PAIN 23 0.0020
403 MATERNAL EXPOSURE DURING PREGNANCY 174 0.0020
404 COVID-19 PNEUMONIA 23 0.0019
405 MOUTH ULCERATION 41 0.0019
406 FACIAL BONES FRACTURE 7 0.0019
407 JOINT RANGE OF MOTION DECREASED 26 0.0019
408 SKIN LACERATION 21 0.0019
409 RASH 839 0.0019
410 LIP SWELLING 64 0.0019
411 FOOD INTOLERANCE 7 0.0019
412 DERMATITIS 40 0.0019
413 SKIN FISSURES 37 0.0019
414 CEREBRAL DISORDER 14 0.0019
415 RASH GENERALISED 49 0.0019
416 OSTEOARTHRITIS 80 0.0019
417 OROPHARYNGEAL DISCOMFORT 17 0.0019
418 HEPATIC ENZYME INCREASED 128 0.0019
419 INTERVERTEBRAL DISC PROTRUSION 41 0.0019
420 SINUS DISORDER 37 0.0019
421 SKIN EXFOLIATION 157 0.0019
422 GAIT INABILITY 62 0.0019
423 AUTOIMMUNE THYROIDITIS 7 0.0018
424 IRON DEFICIENCY ANAEMIA 17 0.0018
425 DERMATITIS CONTACT 21 0.0018
426 JOINT STIFFNESS 48 0.0018
427 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 31 0.0018
428 MELANOCYTIC NAEVUS 8 0.0018
429 FOOT OPERATION 9 0.0018
430 OESOPHAGEAL DISORDER 7 0.0018
431 INJECTION SITE NODULE 20 0.0018
432 LIGAMENT RUPTURE 8 0.0018
433 ABDOMINAL ABSCESS 8 0.0018
434 ANEURYSM 9 0.0018
435 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 33 0.0018
436 NEOPLASM MALIGNANT 119 0.0018
437 IRON DEFICIENCY 8 0.0018
438 POSTOPERATIVE WOUND INFECTION 12 0.0018
439 TOOTHACHE 32 0.0018
440 ERYTHEMA 361 0.0018
441 THERAPEUTIC PRODUCT EFFECT DELAYED 8 0.0018
442 ACCIDENTAL OVERDOSE 64 0.0017
443 STENT PLACEMENT 14 0.0017
444 SKIN WARM 10 0.0017
445 DENTAL CARIES 19 0.0017
446 BLISTER 96 0.0017
447 ALOPECIA 335 0.0017
448 UPPER-AIRWAY COUGH SYNDROME 14 0.0017
449 PRODUCT SUPPLY ISSUE 12 0.0017
450 LIMB OPERATION 8 0.0017
451 HIP SURGERY 9 0.0017
452 HUMERUS FRACTURE 8 0.0017
453 HELICOBACTER INFECTION 17 0.0017
454 NASAL DISCOMFORT 13 0.0016
455 PRODUCT PRESCRIBING ERROR 39 0.0016
456 RASH ERYTHEMATOUS 78 0.0016
457 LIVER FUNCTION TEST INCREASED 35 0.0016
458 WRONG PRODUCT ADMINISTERED 11 0.0016
459 LIMB INJURY 44 0.0016
460 LIGAMENT SPRAIN 16 0.0016
461 SCOLIOSIS 10 0.0016
462 CONDITION AGGRAVATED 490 0.0016
463 IMMUNODEFICIENCY 24 0.0016
464 SUNBURN 12 0.0016
465 RESPIRATORY SYNCYTIAL VIRUS INFECTION 14 0.0016
466 THERAPY PARTIAL RESPONDER 25 0.0016
467 HEPATIC CIRRHOSIS 30 0.0016
468 CHOLECYSTITIS ACUTE 9 0.0016
469 DRUG TOLERANCE 8 0.0016
470 ESCHERICHIA INFECTION 13 0.0016
471 NEEDLE ISSUE 46 0.0016
472 HEPATOCELLULAR CARCINOMA 12 0.0016
473 SEASONAL ALLERGY 22 0.0016
474 CONCUSSION 12 0.0015
475 PAIN 950 0.0015
476 GLOMERULAR FILTRATION RATE DECREASED 19 0.0015
477 HERPES SIMPLEX 10 0.0015
478 GASTROINTESTINAL INFLAMMATION 12 0.0015
479 NASAL CONGESTION 90 0.0015
480 BRAIN FOG 24 0.0015
481 URINE ODOUR ABNORMAL 9 0.0015
482 ARTERIAL OCCLUSIVE DISEASE 12 0.0015
483 SENSITIVITY TO WEATHER CHANGE 8 0.0015
484 TONGUE DISORDER 11 0.0015
485 POLYARTHRITIS 8 0.0015
486 NERVE COMPRESSION 14 0.0015
487 THROAT TIGHTNESS 41 0.0015
488 BLOOD CHOLESTEROL ABNORMAL 7 0.0015
489 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
490 GINGIVAL PAIN 12 0.0015
491 APHONIA 21 0.0015
492 STOMATITIS 91 0.0015
493 DEFORMITY 14 0.0015
494 GASTROINTESTINAL MOTILITY DISORDER 8 0.0015
495 SKIN HAEMORRHAGE 22 0.0015
496 NEOPLASM 17 0.0015
497 FOOT FRACTURE 28 0.0015
498 CARDIAC FAILURE CONGESTIVE 118 0.0015
499 ROAD TRAFFIC ACCIDENT 61 0.0015
500 GALLBLADDER DISORDER 26 0.0015
501 ASTHENOPIA 8 0.0015
502 PHOTOSENSITIVITY REACTION 24 0.0015
503 ALANINE AMINOTRANSFERASE INCREASED 89 0.0014
504 PAIN OF SKIN 39 0.0014
505 SWOLLEN TONGUE 45 0.0014
506 BURNING SENSATION 101 0.0014
507 ORAL DISCOMFORT 20 0.0014
508 FORMICATION 10 0.0014
509 AUTOIMMUNE DISORDER 14 0.0014
510 NASAL DRYNESS 9 0.0014
511 FOOD ALLERGY 11 0.0014
512 SENSATION OF FOREIGN BODY 12 0.0014
513 JOINT DISLOCATION 15 0.0014
514 INFLAMMATORY MARKER INCREASED 7 0.0014
515 PNEUMONIA 457 0.0014
516 PULMONARY MASS 21 0.0014
517 RHEUMATOID ARTHRITIS 160 0.0014
518 UROSEPSIS 13 0.0014
519 ROTATOR CUFF SYNDROME 18 0.0014
520 HYSTERECTOMY 12 0.0014
521 DRUG SPECIFIC ANTIBODY PRESENT 9 0.0014
522 SYSTEMIC LUPUS ERYTHEMATOSUS 49 0.0014
523 TENDON DISORDER 9 0.0014
524 HIP ARTHROPLASTY 21 0.0014
525 RESPIRATORY DISORDER 41 0.0014
526 UTERINE CANCER 11 0.0014
527 EAR DISCOMFORT 14 0.0014
528 SENSITIVE SKIN 10 0.0014
529 BACK DISORDER 22 0.0014
530 DERMATITIS ALLERGIC 17 0.0014
531 DUODENAL ULCER PERFORATION 10 0.0013
532 DISCOMFORT 82 0.0013
533 BREAST MASS 9 0.0013
534 GENERAL PHYSICAL CONDITION ABNORMAL 9 0.0013
535 FIBROMYALGIA 32 0.0013
536 RHINORRHOEA 85 0.0013
537 SWELLING FACE 85 0.0013
538 DIARRHOEA 840 0.0013
539 HAIR GROWTH ABNORMAL 9 0.0013
540 CONCOMITANT DISEASE AGGRAVATED 8 0.0013
541 TENDON RUPTURE 16 0.0013
542 ORAL PAIN 29 0.0013
543 PYREXIA 448 0.0013
544 HERNIA 25 0.0013
545 GASTRIC DISORDER 44 0.0013
546 ADVERSE REACTION 17 0.0013
547 RASH MACULAR 44 0.0013
548 UPPER LIMB FRACTURE 25 0.0013
549 PRODUCT COMMUNICATION ISSUE 11 0.0012
550 THYROID CANCER 15 0.0012
551 PERIORBITAL SWELLING 7 0.0012
552 CLOSTRIDIUM DIFFICILE INFECTION 27 0.0012
553 MALAISE 542 0.0012
554 BREAST CANCER 115 0.0012
555 ANKLE FRACTURE 19 0.0012
556 ABDOMINAL DISCOMFORT 205 0.0012
557 SKIN DISCOLOURATION 56 0.0012
558 IMPAIRED HEALING 40 0.0012
559 CORONARY ARTERY BYPASS 7 0.0012
560 MOUTH SWELLING 7 0.0012
561 SLEEP APNOEA SYNDROME 23 0.0012
562 ASPARTATE AMINOTRANSFERASE INCREASED 64 0.0012
563 PNEUMONIA BACTERIAL 11 0.0012
564 POST PROCEDURAL COMPLICATION 23 0.0012
565 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
566 EAR PAIN 23 0.0012
567 DEVICE MALFUNCTION 83 0.0012
568 NECK PAIN 66 0.0012
569 PARAESTHESIA ORAL 17 0.0012
570 ACCIDENT 14 0.0012
571 SCAR 20 0.0012
572 SKIN CANCER 25 0.0012
573 ACNE 88 0.0012
574 GASTRIC ULCER 22 0.0012
575 PAIN IN EXTREMITY 341 0.0012
576 EYE SWELLING 43 0.0012
577 MIGRAINE 110 0.0012
578 REBOUND EFFECT 13 0.0011
579 DRUG EFFECT LESS THAN EXPECTED 17 0.0011
580 ADVERSE DRUG REACTION 103 0.0011
581 LOWER LIMB FRACTURE 22 0.0011
582 WOUND 32 0.0011
583 TOOTH EXTRACTION 14 0.0011
584 ANAPHYLACTIC REACTION 62 0.0011
585 EPSTEIN-BARR VIRUS INFECTION 7 0.0011
586 LUNG NEOPLASM MALIGNANT 46 0.0011
587 OVERDOSE 238 0.0011
588 HYPERHIDROSIS 142 0.0011
589 ABNORMAL FAECES 9 0.0011
590 GASTROENTERITIS 16 0.0011
591 DYSSTASIA 32 0.0011
592 ENTERITIS 7 0.0011
593 LACRIMATION INCREASED 33 0.0011
594 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 51 0.0011
595 GASTROINTESTINAL PAIN 12 0.0011
596 TOOTH FRACTURE 12 0.0011
597 HAEMATOCHEZIA 60 0.0011
598 MENSTRUAL DISORDER 9 0.0011
599 HYPERTENSION 230 0.0011
600 MOBILITY DECREASED 77 0.0011
601 SNEEZING 24 0.0011
602 DIABETES MELLITUS 81 0.0011
603 FEELING HOT 65 0.0011
604 PAROSMIA 8 0.0011
605 SEPSIS 118 0.0011
606 BLOOD URINE PRESENT 20 0.0011
607 ACUTE MYOCARDIAL INFARCTION 31 0.0011
608 CHILLS 123 0.0010
609 PRODUCT USE ISSUE 197 0.0010
610 SKIN BURNING SENSATION 75 0.0010
611 HYPOACUSIS 45 0.0010
612 TYPE 2 DIABETES MELLITUS 35 0.0010
613 CONTUSION 100 0.0010
614 PYELONEPHRITIS 9 0.0010
615 SKIN SWELLING 9 0.0010
616 FEEDING DISORDER 21 0.0010
617 EYELID OEDEMA 12 0.0010
618 RENAL DISORDER 48 0.0010
619 PELVIC FRACTURE 8 0.0010
620 COUGH 286 0.0010
621 HEPATOMEGALY 10 0.0010
622 JOINT EFFUSION 7 0.0010
623 LIVER DISORDER 45 0.0010
624 LYMPHOEDEMA 7 0.0010
625 CHOLECYSTITIS 12 0.0010
626 BLADDER DISORDER 10 0.0010
627 CHOLELITHIASIS 33 0.0010
628 DYSURIA 37 0.0010
629 WRIST FRACTURE 12 0.0010
630 CARPAL TUNNEL SYNDROME 14 0.0010
631 MUSCULOSKELETAL DISORDER 19 0.0010
632 FOOT DEFORMITY 11 0.0010
633 EMPHYSEMA 10 0.0010
634 LIP DRY 9 0.0010
635 MYASTHENIA GRAVIS 8 0.0010
636 FRUSTRATION TOLERANCE DECREASED 8 0.0010
637 MUSCLE DISORDER 8 0.0010
638 MUSCULOSKELETAL DISCOMFORT 17 0.0010
639 EXOSTOSIS 9 0.0010
640 ABDOMINAL PAIN 229 0.0010
641 DRY THROAT 10 0.0010
642 RASH PAPULAR 22 0.0010
643 BACK PAIN 228 0.0010
644 INTESTINAL PERFORATION 11 0.0010
645 BRAIN NEOPLASM 9 0.0010
646 NAUSEA 773 0.0010
647 OVARIAN CANCER 9 0.0010
648 PHARYNGEAL OEDEMA 15 0.0010
649 HAEMORRHOIDS 19 0.0010
650 DRUG DOSE OMISSION 161 0.0010
651 INJECTION SITE EXTRAVASATION 12 0.0010
652 RIB FRACTURE 20 0.0010
653 ANAPHYLACTIC SHOCK 25 0.0010
654 MYOCARDIAL INFARCTION 169 0.0010
655 POOR VENOUS ACCESS 10 0.0010
656 ERYTHEMA MULTIFORME 9 0.0010
657 HYPOKINESIA 14 0.0010
658 FREQUENT BOWEL MOVEMENTS 26 0.0010
659 ABDOMINAL PAIN UPPER 198 0.0010
660 EOSINOPHIL COUNT INCREASED 8 0.0010
661 CHEST DISCOMFORT 98 0.0010
662 MOOD ALTERED 26 0.0010
663 PERICARDITIS 16 0.0010
664 COLON CANCER 14 0.0009
665 TASTE DISORDER 19 0.0009
666 HIP FRACTURE 30 0.0009
667 INTERSTITIAL LUNG DISEASE 45 0.0009
668 MYALGIA 158 0.0009
669 HYPOAESTHESIA ORAL 14 0.0009
670 HEPATIC FAILURE 28 0.0009
671 BLOOD IRON DECREASED 11 0.0009
672 PRODUCT STORAGE ERROR 81 0.0009
673 HEADACHE 579 0.0009
674 BLINDNESS UNILATERAL 13 0.0009
675 BACK INJURY 10 0.0009
676 MENTAL DISORDER 40 0.0009
677 COELIAC DISEASE 9 0.0009
678 GAIT DISTURBANCE 175 0.0009
679 GLYCOSYLATED HAEMOGLOBIN INCREASED 23 0.0009
680 SPINAL OSTEOARTHRITIS 8 0.0009
681 PANCREATITIS 48 0.0009
682 BLOOD TRIGLYCERIDES INCREASED 16 0.0009
683 DRUG EFFECT DECREASED 48 0.0009
684 ANAL INCONTINENCE 8 0.0009
685 OSTEONECROSIS 29 0.0009
686 LUPUS-LIKE SYNDROME 8 0.0009
687 NERVOUSNESS 46 0.0009
688 GINGIVAL BLEEDING 12 0.0009
689 SECRETION DISCHARGE 11 0.0009
690 MICTURITION URGENCY 10 0.0009
691 THROMBOSIS 70 0.0009
692 VERTIGO 53 0.0009
693 FATIGUE 674 0.0009
694 HOSPITALISATION 133 0.0009
695 NEURALGIA 21 0.0009
696 VISUAL IMPAIRMENT 107 0.0009
697 EYE PRURITUS 29 0.0009
698 CEREBROVASCULAR ACCIDENT 144 0.0008
699 LEUKAEMIA 8 0.0008
700 THROAT IRRITATION 38 0.0008
701 MUSCULOSKELETAL CHEST PAIN 13 0.0008
702 WEIGHT DECREASED 233 0.0008
703 BODY TEMPERATURE INCREASED 17 0.0008
704 PROSTATE CANCER 67 0.0008
705 GASTROOESOPHAGEAL REFLUX DISEASE 67 0.0008
706 CHEST PAIN 153 0.0008
707 WOUND INFECTION 9 0.0008
708 UNEVALUABLE EVENT 62 0.0008
709 SCIATICA 13 0.0008
710 ABDOMINAL DISTENSION 85 0.0008
711 SINUS CONGESTION 11 0.0008
712 DRY SKIN 108 0.0008
713 MUSCLE TIGHTNESS 13 0.0008
714 SYRINGE ISSUE 14 0.0008
715 PREGNANCY 16 0.0008
716 ABORTION SPONTANEOUS 32 0.0008
717 RETCHING 17 0.0008
718 GROIN PAIN 7 0.0008
719 TOXIC SKIN ERUPTION 8 0.0008
720 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 56 0.0008
721 WHITE BLOOD CELL COUNT INCREASED 30 0.0008
722 SYNCOPE 78 0.0008
723 DISEASE RECURRENCE 37 0.0008
724 NIGHT SWEATS 25 0.0008
725 LOWER RESPIRATORY TRACT INFECTION 35 0.0008
726 FEELING ABNORMAL 184 0.0008
727 PETECHIAE 8 0.0008
728 BLADDER CANCER 45 0.0008
729 SKIN IRRITATION 35 0.0008
730 GLOSSODYNIA 17 0.0008
731 DEPRESSION 172 0.0008
732 RENAL PAIN 8 0.0008
733 HEPATITIS C 9 0.0007
734 FULL BLOOD COUNT DECREASED 15 0.0007
735 RENAL IMPAIRMENT 62 0.0007
736 CARDIAC DISORDER 69 0.0007
737 MEMORY IMPAIRMENT 101 0.0007
738 BLOOD POTASSIUM DECREASED 22 0.0007
739 EYE DISORDER 24 0.0007
740 OFF LABEL USE 639 0.0007
741 GLAUCOMA 14 0.0007
742 HEAD INJURY 23 0.0007
743 ECONOMIC PROBLEM 11 0.0007
744 LIVER FUNCTION TEST ABNORMAL 21 0.0007
745 GASTRITIS 19 0.0007
746 AGEUSIA 18 0.0007
747 DEPRESSED MOOD 38 0.0007
748 HEPATOTOXICITY 16 0.0007
749 MALNUTRITION 8 0.0007
750 BONE DISORDER 13 0.0007
751 PRODUCTIVE COUGH 34 0.0007
752 LUNG INFECTION 11 0.0007
753 DISABILITY 14 0.0007
754 LYMPHOPENIA 10 0.0007
755 INABILITY TO AFFORD MEDICATION 7 0.0007
756 BLOOD PRESSURE ABNORMAL 14 0.0007
757 INTERNAL HAEMORRHAGE 8 0.0007
758 PRESYNCOPE 17 0.0007
759 CEREBRAL INFARCTION 17 0.0007
760 FALL 231 0.0007
761 WEIGHT INCREASED 155 0.0007
762 ANOSMIA 10 0.0007
763 ASTHMA 78 0.0007
764 BLOOD CHOLESTEROL INCREASED 32 0.0007
765 ADVERSE EVENT 63 0.0007
766 RESTLESSNESS 25 0.0007
767 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
768 LIMB DISCOMFORT 21 0.0007
769 DRY MOUTH 55 0.0007
770 POLLAKIURIA 28 0.0007
771 DRUG-INDUCED LIVER INJURY 21 0.0007
772 INFUSION RELATED REACTION 44 0.0007
773 INTESTINAL OBSTRUCTION 25 0.0007
774 DRY EYE 33 0.0007
775 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
776 PANIC ATTACK 24 0.0007
777 DEVICE DELIVERY SYSTEM ISSUE 18 0.0007
778 PRODUCT USE IN UNAPPROVED INDICATION 162 0.0007
779 VOMITING 307 0.0007
780 THYROID DISORDER 10 0.0006
781 DEMENTIA 18 0.0006
782 OESOPHAGITIS 7 0.0006
783 MENINGIOMA 10 0.0006
784 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
785 PAIN IN JAW 18 0.0006
786 DIALYSIS 9 0.0006
787 ANXIETY 180 0.0006
788 PROTEINURIA 12 0.0006
789 MUSCULOSKELETAL PAIN 33 0.0006
790 TOOTH DISORDER 14 0.0006
791 HYPERTENSIVE CRISIS 7 0.0006
792 OBESITY 10 0.0006
793 OCULAR DISCOMFORT 7 0.0006
794 DIABETES MELLITUS INADEQUATE CONTROL 11 0.0006
795 HEAD DISCOMFORT 11 0.0006
796 PULMONARY EMBOLISM 59 0.0006
797 HIATUS HERNIA 8 0.0006
798 INSOMNIA 164 0.0006
799 BLOOD PRESSURE INCREASED 94 0.0006
800 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 32 0.0006
801 HAEMATURIA 21 0.0006
802 MUSCLE SPASMS 112 0.0006
803 MULTIPLE FRACTURES 10 0.0006
804 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 123 0.0006
805 HAEMORRHAGE 63 0.0006
806 DYSPHAGIA 57 0.0006
807 DEHYDRATION 80 0.0006
808 PRODUCT PRESCRIBING ISSUE 13 0.0006
809 ILL-DEFINED DISORDER 36 0.0006
810 DRUG DOSE OMISSION BY DEVICE 46 0.0006
811 PANCREATITIS ACUTE 13 0.0006
812 CRYING 21 0.0006
813 ACUTE MYELOID LEUKAEMIA 9 0.0006
814 FEELING COLD 16 0.0006
815 CARDIOMEGALY 7 0.0006
816 OCULAR HYPERAEMIA 27 0.0006
817 ATRIAL FIBRILLATION 55 0.0006
818 DIZZINESS 281 0.0006
819 PERICARDIAL EFFUSION 13 0.0006
820 ANGER 19 0.0006
821 HYPOAESTHESIA 84 0.0006
822 RECTAL HAEMORRHAGE 24 0.0006
823 SEIZURE 64 0.0006
824 HYPERTHYROIDISM 8 0.0006
825 PALLOR 15 0.0006
826 HEPATIC CYTOLYSIS 7 0.0005
827 DYSPEPSIA 54 0.0005
828 DYSPHONIA 32 0.0005
829 FLATULENCE 31 0.0005
830 DRUG RESISTANCE 14 0.0005
831 CYTOMEGALOVIRUS INFECTION 9 0.0005
832 MENTAL IMPAIRMENT 13 0.0005
833 FACE OEDEMA 9 0.0005
834 FLUID RETENTION 27 0.0005
835 LIVER INJURY 13 0.0005
836 SEPTIC SHOCK 23 0.0005
837 RENAL CANCER 25 0.0005
838 CARDIAC FAILURE 42 0.0005
839 MULTIPLE SCLEROSIS 25 0.0005
840 LETHARGY 30 0.0005
841 PARAESTHESIA 82 0.0005
842 BLOOD GLUCOSE INCREASED 98 0.0005
843 CHOKING 10 0.0005
844 DYSGEUSIA 38 0.0005
845 POOR QUALITY SLEEP 11 0.0005
846 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 28 0.0005
847 SLEEP DISORDER 36 0.0005
848 LABORATORY TEST ABNORMAL 15 0.0005
849 SPINAL FRACTURE 10 0.0005
850 GAMMA-GLUTAMYLTRANSFERASE INCREASED 11 0.0005
851 DEEP VEIN THROMBOSIS 32 0.0005
852 LUNG DISORDER 24 0.0005
853 PARALYSIS 7 0.0005
854 DEVICE LEAKAGE 21 0.0005
855 BLOOD PRESSURE DECREASED 32 0.0005
856 CONSTIPATION 105 0.0005
857 TINNITUS 22 0.0005
858 BONE PAIN 28 0.0005
859 HEART RATE INCREASED 47 0.0005
860 HEMIPARESIS 8 0.0005
861 DYSPNOEA 267 0.0005
862 COGNITIVE DISORDER 22 0.0005
863 INCREASED APPETITE 9 0.0005
864 HYPOTHYROIDISM 15 0.0005
865 HYPOPHAGIA 12 0.0005
866 CHOLESTASIS 9 0.0005
867 DEATH 402 0.0005
868 MUSCULAR WEAKNESS 53 0.0005
869 HOT FLUSH 35 0.0005
870 PALPITATIONS 54 0.0005
871 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
872 GENERAL PHYSICAL HEALTH DETERIORATION 53 0.0005
873 EPILEPSY 14 0.0005
874 HEPATIC CANCER 11 0.0005
875 WHEEZING 27 0.0005
876 ANGINA PECTORIS 13 0.0005
877 THIRST 8 0.0004
878 LOSS OF CONSCIOUSNESS 57 0.0004
879 BALANCE DISORDER 38 0.0004
880 MOOD SWINGS 14 0.0004
881 DECREASED APPETITE 102 0.0004
882 URINARY INCONTINENCE 13 0.0004
883 BLOOD GLUCOSE DECREASED 21 0.0004
884 SUICIDAL IDEATION 40 0.0004
885 DERMATITIS ATOPIC 23 0.0004
886 MOVEMENT DISORDER 14 0.0004
887 FLUSHING 44 0.0004
888 BLOOD CREATININE INCREASED 28 0.0004
889 ASTHENIA 161 0.0004
890 ACCIDENTAL EXPOSURE TO PRODUCT 44 0.0004
891 EATING DISORDER 9 0.0004
892 ANAEMIA 80 0.0004
893 BLINDNESS 17 0.0004
894 WHITE BLOOD CELL COUNT DECREASED 45 0.0004
895 BREAST CANCER FEMALE 11 0.0004
896 EYE PAIN 23 0.0004
897 TRANSAMINASES INCREASED 9 0.0004
898 PULMONARY OEDEMA 18 0.0004
899 EOSINOPHILIA 7 0.0004
900 IRRITABILITY 24 0.0004
901 CHROMATURIA 9 0.0004
902 COLD SWEAT 7 0.0004
903 PRODUCT ADMINISTRATION ERROR 8 0.0004
904 ABDOMINAL PAIN LOWER 10 0.0004
905 PRODUCT AVAILABILITY ISSUE 9 0.0004
906 CARDIOVASCULAR DISORDER 10 0.0004
907 ISCHAEMIC STROKE 7 0.0004
908 OEDEMA 21 0.0004
909 LEUKOCYTOSIS 7 0.0004
910 CATARACT 23 0.0004
911 NERVOUS SYSTEM DISORDER 12 0.0004
912 TREATMENT NONCOMPLIANCE 21 0.0004
913 HYPERSOMNIA 11 0.0004
914 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 11 0.0004
915 INJURY 26 0.0004
916 FAECES DISCOLOURED 8 0.0004
917 EYE IRRITATION 21 0.0004
918 TACHYCARDIA 32 0.0004
919 STEVENS-JOHNSON SYNDROME 8 0.0004
920 DRUG EFFECT INCOMPLETE 13 0.0004
921 NEUROPATHY PERIPHERAL 34 0.0004
922 HAEMATEMESIS 9 0.0004
923 HEART RATE IRREGULAR 8 0.0004
924 INTENTIONAL PRODUCT USE ISSUE 31 0.0004
925 RENAL FAILURE 46 0.0003
926 PSYCHOTIC DISORDER 10 0.0003
927 CEREBRAL HAEMORRHAGE 12 0.0003
928 VISION BLURRED 46 0.0003
929 FEAR 9 0.0003
930 BLOOD PRESSURE FLUCTUATION 8 0.0003
931 APHASIA 10 0.0003
932 HAEMOGLOBIN DECREASED 34 0.0003
933 CORONARY ARTERY DISEASE 10 0.0003
934 SOMNOLENCE 65 0.0003
935 CONFUSIONAL STATE 52 0.0003
936 OEDEMA PERIPHERAL 39 0.0003
937 OSTEOPOROSIS 13 0.0003
938 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
939 DIPLOPIA 8 0.0003
940 PLASMA CELL MYELOMA 12 0.0003
941 ASCITES 9 0.0003
942 EXPOSURE DURING PREGNANCY 19 0.0003
943 PLEURAL EFFUSION 18 0.0003
944 TREMOR 49 0.0003
945 EPISTAXIS 22 0.0003
946 PNEUMONITIS 8 0.0003
947 PLATELET COUNT DECREASED 30 0.0003
948 RED BLOOD CELL COUNT DECREASED 8 0.0003
949 DISTURBANCE IN ATTENTION 15 0.0003
950 PANCREATIC CARCINOMA 8 0.0003
951 ARRHYTHMIA 13 0.0003
952 COMA 13 0.0003
953 EXPIRED PRODUCT ADMINISTERED 9 0.0003
954 FOETAL EXPOSURE DURING PREGNANCY 22 0.0003
955 HAEMATOMA 7 0.0003
956 EXPOSURE VIA SKIN CONTACT 7 0.0003
957 ACUTE KIDNEY INJURY 41 0.0003
958 SPEECH DISORDER 14 0.0003
959 NO ADVERSE EVENT 48 0.0003
960 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
961 MENSTRUATION IRREGULAR 7 0.0003
962 THROMBOCYTOPENIA 29 0.0003
963 BLOOD BILIRUBIN INCREASED 7 0.0003
964 HEART RATE DECREASED 9 0.0003
965 HAEMOPTYSIS 7 0.0003
966 RESPIRATORY FAILURE 18 0.0002
967 AMNESIA 16 0.0002
968 URINARY RETENTION 8 0.0002
969 DEVICE ISSUE 21 0.0002
970 CARDIAC ARREST 19 0.0002
971 EMOTIONAL DISORDER 7 0.0002
972 RHABDOMYOLYSIS 9 0.0002
973 OXYGEN SATURATION DECREASED 12 0.0002
974 CHRONIC KIDNEY DISEASE 16 0.0002
975 NEUTROPENIA 27 0.0002
976 DYSKINESIA 8 0.0002
977 DRUG INTERACTION 30 0.0002
978 DYSARTHRIA 7 0.0002
979 AGGRESSION 8 0.0002
980 HYPOTENSION 32 0.0002
981 EMOTIONAL DISTRESS 19 0.0002
982 HYPONATRAEMIA 8 0.0001
983 INTENTIONAL PRODUCT MISUSE 12 0.0001
984 DISEASE PROGRESSION 16 0.0001
985 SUICIDE ATTEMPT 8 0.0001
986 PRODUCT QUALITY ISSUE 8 0.0001